50242-0077 Herceptin Hylecta

Product NDC:

50242-0077

Brand Name:

Herceptin Hylecta

Generic Name:

Trastuzumab and Hyaluronidase-oysk

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: HYALURONIDASE

Strength: 10000.0

Unit: U/5mL

Name: HYALURONIDASE (HUMAN RECOMBINANT)

Strength: 10000.0

Unit: U/5mL

Name: TRASTUZUMAB

Strength: 600.0

Unit: mg/5mL

Packages:

Code: 50242-0077-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-077-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Feb. 28, 2019

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox